Trevi Therapeutics Ownership | Who Owns Trevi Therapeutics?
Trevi Therapeutics Ownership Summary
Trevi Therapeutics is owned by 66.86% institutional investors, 1.05% insiders, and 32.09% retail investors. Nea management company is the largest institutional shareholder, holding 11.25% of TRVI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.40% of its assets in Trevi Therapeutics shares.
TRVI Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Trevi Therapeutics | 66.86% | 1.05% | 32.09% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Nea management company | 11.37M | 11.25% | $48.85M |
Frazier life sciences management | 7.38M | 7.42% | $22.00M |
Viking global investors lp | 4.40M | 4.35% | $18.13M |
Rubric capital management lp | 4.21M | 4.16% | $17.33M |
Point72 asset management | 4.15M | 4.11% | $17.10M |
Blackrock funding, inc. /de | 3.93M | 3.89% | $16.19M |
Vanguard group | 3.51M | 3.47% | $14.46M |
Vivo capital | 3.49M | 3.45% | $14.37M |
Woodline partners lp | 3.21M | 3.18% | $13.24M |
Blackrock | 3.14M | 3.15% | $9.34M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Acuta capital partners | 771.96K | 3.20% | $3.18M |
Ally bridge group (ny) | 781.49K | 2.76% | $3.22M |
Nea management company | 11.37M | 2.76% | $48.85M |
Checkpoint capital | 1.08M | 2.27% | $4.47M |
Rosalind advisors | 1.06M | 2.24% | $4.38M |
Bioimpact capital | 3.09M | 1.81% | $12.75M |
Opaleye management | 2.32M | 1.67% | $9.55M |
Vivo capital | 3.49M | 1.61% | $14.37M |
Frazier life sciences management | 7.38M | 1.03% | $22.00M |
Silverarc capital management | 734.23K | 0.66% | $3.03M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Point72 asset management | 4.15M | 0.04% | 4.15M |
Siren | 2.91M | 0.53% | 2.91M |
Woodline partners lp | 3.21M | 0.09% | 2.61M |
Adage capital partners gp | 2.50M | 0.02% | 2.50M |
Vivo capital | 3.49M | 1.61% | 1.88M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Vr adviser | 1.27M | 0.36% | -2.16M |
Logos global management lp | 1.25M | 0.60% | -1.50M |
Rubric capital management lp | 4.21M | 0.22% | -821.80K |
Ally bridge group (ny) | 781.49K | 2.76% | -541.31K |
Landscape capital management | 52.09K | 0.02% | -372.64K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Point72 asset management | 4.15M | 0.04% | 4.15M | $17.10M |
Siren | 2.91M | 0.53% | 2.91M | $11.97M |
Adage capital partners gp | 2.50M | 0.02% | 2.50M | $10.30M |
Ikarian capital | 325.00K | 0.18% | 325.00K | $1.34M |
Two sigma investments, lp | 135.81K | 0.00% | 135.81K | $559.52K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -6.00 |
Steward partners investment advisory | -25.00 |
Nisa investment advisors | -84.00 |
Capital performance advisors llp | -134.00 |
Federated hermes | -598.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 107 | 10.31% | 67,554,275 | 16.23% | 66 | 2.02% | 66 | 34.69% | 25 | 31.58% |
Sep 30, 2024 | 97 | 25.97% | 58,119,888 | 3.96% | 57 | 1.82% | 49 | 13.95% | 19 | 26.67% |
Jun 30, 2024 | 77 | -4.94% | 55,906,687 | 8.43% | 56 | 2.07% | 43 | 16.22% | 15 | -44.44% |
Mar 31, 2024 | 81 | 24.62% | 51,561,502 | -1.29% | 52 | 1.88% | 37 | -2.63% | 27 | 92.86% |
Dec 31, 2023 | 65 | 18.18% | 52,235,708 | 7.30% | 52 | 2.16% | 38 | 100.00% | 14 | -17.65% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.24M | 2.40% | - |
iShares Russell 2000 ETF | 1.95M | 2.02% | -16.94K |
Vanguard US Total Market Shares ETF | 1.78M | 1.84% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 767.27K | 0.82% | 11.86K |
Fidelity Small Cap Index | 591.65K | 0.61% | -11.08K |
iShares Russell 2000 Growth ETF | 396.84K | 0.41% | -1.89K |
State St Russell Sm/Mid Cp® Indx SL Cl I | 345.20K | 0.36% | 88.77K |
iShares Biotechnology ETF | 337.56K | 0.35% | -3.76K |
Fidelity Extended Market Index | 301.53K | 0.31% | -1.92K |
Vanguard Russell 2000 ETF | 281.32K | 0.30% | 6.48K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 25, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | $17.36K |
Mar 21, 2025 | GOOD JENNIFER L | President & CEO | Sell | $34.62K |
Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Sell | $31.10K |
Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Sell | $517.78K |
Sep 06, 2024 | GOOD JENNIFER L | President & CEO | Sell | $12.78K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 4 |
2024 Q4 | - | - |
2024 Q3 | - | 10 |
2024 Q2 | - | 4 |
2024 Q1 | - | - |
TRVI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools